PSMA7 Antibody (Center) Blocking Peptide

Artikelnummer: ABT-BP8659C
Artikelname: PSMA7 Antibody (Center) Blocking Peptide
Artikelnummer: ABT-BP8659C
Hersteller Artikelnummer: BP8659c
Alternativnummer: ABT-BP8659C-500UG
Hersteller: Abcepta
Kategorie: Proteine/Peptide
Alternative Synonym: Proteasome subunit alpha type-7, Proteasome subunit RC6-1, Proteasome subunit XAPC7, PSMA7, HSPC
The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits, 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. PSMA7 is a member of the peptidase T1A family, that is a 20S core alpha subunit. This particular subunit has been shown to interact specifically with the hepatitis B virus X protein, a protein critical to viral replication. In addition, this subunit is involved in regulating hepatitis virus C internal ribosome entry site (IRES) activity, an activity essential for viral replication. This core alpha subunit is also involved in regulating the hypoxia-inducible factor-1alpha, a transcription factor important for cellular responses to oxygen tension.
NCBI: 5688
UniProt: O14818
Formulierung: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Target-Kategorie: The synthetic peptide sequence used to generate the antibody AP8659c was selected from the Center region of human PSMA7. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.